This issue brief investigates how the cost of prescription drugs affects the total cost of care for people with multiple sclerosis (MS). It decomposes total health care spending by category, specifically separating out spending on specialty drugs used to treat MS, called Disease Modifying Therapies (DMTs). The issue brief subsequently examines whether changes in spending on DMTs are due to changes...
ABSTRACT Background: Laparotomy followed by inpatient hospitalization has traditionally been the most common surgical care for hysterectomy. The financial implications of the increased use of laparoscopy and outpatient hysterectomy are unknown. Objectives: The objective of the study was to quantify the increasing use of laparoscopy and outpatient hysterectomy and to describe the financial implicat...
On February 28, 2018, HCCI, among other key stakeholders, was asked to provide feedback to several questions posed by six U.S. Senators on the issue of health care price transparency. The Senators are launching a bipartisan effort to increase health care price and information transparency to empower patients, improve the quality of health care, and lower health care costs. Feedback was due March 2...
By: Tami Luhby Sylvia Rosas decided to go to the emergency room after getting stung by a bee in her yard in Valrico, Florida. She had experienced allergic reactions in the past, but didn't have an EpiPen on hand. However, what really hurt was the $12,000 bill she received for the visit to the ER. The 53-year-old said she was seen by several doctors, who ordered thousands of dollars in b...
By: Christopher Koller and Margaret O'Kane The Health Care Cost Institute (HCCI) released its analysis of 2016 health spending for a group of commercial insurers last month. The report is a trove of information that, like all good analyses, suggests more questions than it answers. Buried in the report—in figure 15—is an alarming trend that should rise to the top of analysts' areas for further inve...
